The Indian government is divided about whether to break a patent on a Bristol-Myers Squibb cancer drug called Dasatinib, which is given for leukemia.

Topics:  indian   bristol-myers squibb   dasatinib   divided   break   drug   patent   

 

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Business News